SonoThera Raises $125 Million for Ultrasound-Delivered Genetic Medicines
The biotechnology company plans to move nonviral treatments for Duchenne muscular dystrophy and polycystic kidney disease toward clinical testing.
Archive
The biotechnology company plans to move nonviral treatments for Duchenne muscular dystrophy and polycystic kidney disease toward clinical testing.
The vertical software company is connecting agency data with AI workflows for policy checks, proposals and other document-heavy tasks.
The autonomous drone maker reached a $4.4 billion valuation as it increases production for defense, public safety and infrastructure customers.
The Santa Clara startup is combining navigation, communications and computing functions in silicon intended for drones and robots.
The Mountain View robotics company reached a $1.15 billion valuation with a plan to begin real household deployments in the fall.